Maven Securities’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-200,000
Closed -$10.4M 1394
2021
Q1
$10.4M Buy
200,000
+180,000
+900% +$9.41M 0.46% 32
2020
Q4
$714K Sell
20,000
-254,870
-93% -$3.61M 0.07% 296
2020
Q3
$3.18M Buy
274,870
+24,870
+10% +$288K 0.26% 82
2020
Q2
$3.31M Buy
250,000
+35,040
+16% +$457K 0.23% 79
2020
Q1
$2.42M Buy
+214,960
New +$2.64M 0.29% 45

Other funds holding DMTK

Maven Securities's DMTK Position: Q2 2021 in Review

Maven Securities sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2021, closing a stake of 200,000 shares — an estimated $10.4M sold.

Maven Securities first reported a position in DMTK in Q1 2020 and held it in 5 quarters. The position peaked at $10.4M in Q1 2021. 176 funds tracked by Wall St. Rank hold DMTK as of Q2 2021.

  • Maven Securities reported no remaining DermTech, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Maven Securities sold 200,000 DermTech, Inc. Common Stock shares in Q2 2021, an estimated $10.4M.
  • Maven Securities first reported a position in DermTech, Inc. Common Stock in Q1 2020 and held it in 5 quarters.
  • Maven Securities's DermTech, Inc. Common Stock position peaked at $10.4M in Q1 2021.
  • 176 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2021.

Based on Maven Securities's 13F filing for Q2 2021, filed 16 Aug 2021.